Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06002152 · ClinicalTrials.gov registry record · Phase 2
Superficial Cervical Plexus Block and Quality of Recovery After Thyroidectomy
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 160
- Enrollment target
NCT06002152 is a Phase 2 study that has completed, run by Yale University. The registered enrollment target is 160 participants.
The verdict
NCT06002152, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 160 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn whether a superficial cervical plexus block improves quality of recovery after thyroid surgery. Investigators will compare a superficial cervical plexus block with bupivacaine compared to an identical procedure performed saline placebo to see if there is a difference in quality of recovery on the first postoperative day. The main question to answer is: • Does a superficial cervical plexus block with bupivacaine compared to placebo improve quality of recovery in patients having thyroid surgery. Participants will: * Fill out an initial preoperative survey * Be randomized to receive a superficial cervical plexus block with bupivacaine or saline placebo while under anesthesia before the surgery starts * Fill out a survey about recovery on the first day after surgery
Interventions
- DRUG Placebo
- DRUG Bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2023-11-27 |
| Est. Completion | 2026-02-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06002152
The ClinicalTrials.gov registry entry for NCT06002152 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06002152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06002152 about?
NCT06002152 is a clinical study titled "Superficial Cervical Plexus Block and Quality of Recovery After Thyroidectomy". The goal of this clinical trial is to learn whether a superficial cervical plexus block improves quality of recovery after thyroid surgery. Investigators will compare a superficial cervical plexus block with bupivacaine compared to an identical procedure performed saline placebo to see if there is a...
What is the current status of trial NCT06002152?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 2023-11-27. Estimated completion is 2026-02-03.
What interventions are being tested in trial NCT06002152?
The interventions under investigation include: Placebo (DRUG), Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT06002152?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.